https://www.selleckchem.com/products/d-1553.html
[This corrects the article DOI 10.1016/j.scs.2020.102692.].Adoptive cellular therapy (ACT) is a potent strategy to boost the immune response against cancer. ACT is effective against blood cancers but faces challenges in treating solid tumors. A critical step for the success of ACT immunotherapy is to achieve efficient trafficking and persistence of T cells to solid tumors. Non-invasive tracking of the accumulation of adoptively transferred T cells to tumors would greatly accelerate development of more effective ACT strategies. We demonst
Beğen
Yorum Yap
Paylaş
